Croda International (LON:CRDA) Insider Purchases £161.22 in Stock

Croda International Plc (LON:CRDA) insider Steve Foots acquired 6 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The stock was bought at an average cost of GBX 2,687 per share, with a total value of £161.22.

Croda International Stock Down 0.1%

CRDA stock opened at GBX 2,715 on Friday. The firm has a market cap of £3.79 billion, a PE ratio of 17.63, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. Croda International Plc has a one year low of GBX 2,426.77 and a one year high of GBX 3,494. The firm’s fifty day moving average is GBX 2,788.37 and its 200 day moving average is GBX 2,780.29.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group cut shares of Croda International to a “hold” rating and reduced their price target for the company from GBX 3,100 to GBX 3,000 in a research report on Tuesday, November 11th. Berenberg Bank lifted their target price on Croda International from GBX 3,100 to GBX 3,300 and gave the stock a “buy” rating in a research report on Thursday, October 16th. Citigroup decreased their target price on Croda International from GBX 3,300 to GBX 3,050 and set a “neutral” rating for the company in a research report on Friday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Croda International from GBX 3,000 to GBX 3,100 and gave the stock a “hold” rating in a research report on Thursday, October 16th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of GBX 3,112.50.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.